Mark de Rosch

Dr. Mark de Rosch is an Executive VP-Regulatory & Government Affairs at CervoMed, Inc. Dr. de Rosch was previously employed as a Chief Operating Officer by Aura Biosciences, Inc., a Chief Regulatory Officer by Epizyme, Inc., a Senior VP-Regulatory Affairs & Quality Assurance by Nightstar Therapeutics Ltd., a Vice President-Regulatory Affairs by Akebia Therapeutics, Inc., a Vice President-Regulatory Affairs by The Christmas Consortium, LLC, a Senior Director-Global Regulatory Strategy by Vertex Pharmaceuticals, Inc., a Director-Regulatory Affairs by Berlex Laboratories, Inc., a Research Chemist by Diatide, Inc., a Research Chemist by Mallinckrodt Medical, Inc., and a VP-Regulatory Drugs & US Operations by Voisin Consulting, Inc. He received his undergraduate degree from the University of Wisconsin Parkside, a graduate degree from the University of California San Diego and a doctorate degree from the University of California San Diego.